Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

NCT04807478 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped New study protocol under development

Conditions

Parenteral Nutrition Associated Liver Disease
Essential Fatty Acid Deficiency
Neurocognitive Deficit
Malnutrition
Pediatric ALL

Interventions

DRUG: Omegaven® (fish oil triglycerides) Injectable Emulsion

Sponsor

Fresenius Kabi